In 2023, the trade exchange (includes international purchases and sales) of Heterocyclic Compounds with Heteroatom / S Nitrogen Exclusively, in the Structure Cycle Pyrazole, Incl. Hydrogenated Unfused (Exc. Phenazone "Antipirina" and Derivatives) was US$20.5M.
In 2021, the states with the most international sales in Heterocyclic Compounds with Heteroatom / S Nitrogen Exclusively, in the Structure Cycle Pyrazole, Incl. Hydrogenated Unfused (Exc. Phenazone "Antipirina" and Derivatives) were Ciudad de México (US$26.3k).
The states with the most international purchases in 2023 were Jalisco (US$4.48M), Estado de México (US$2.25M), and Ciudad de México (US$2.22M).
In 2021, the main commercial destinations of Heterocyclic Compounds with Heteroatom / S Nitrogen Exclusively, in the Structure Cycle Pyrazole, Incl. Hydrogenated Unfused (Exc. Phenazone "Antipirina" and Derivatives) were Ecuador (US$10.8k), Nicaragua (US$9.18k), Venezuela (US$2.48k), Costa Rica (US$2.09k), and Panama (US$1.74k).
The main commercial origins of Heterocyclic Compounds with Heteroatom / S Nitrogen Exclusively, in the Structure Cycle Pyrazole, Incl. Hydrogenated Unfused (Exc. Phenazone "Antipirina" and Derivatives) in 2023 were China (US$6.15M), Germany (US$1.84M), India (US$947k), United States (US$5.12k), and France (US$1.13k).
In the global context, the main exporting countries of Heterocyclic Compounds with Heteroatom / S Nitrogen Exclusively, in the Structure Cycle Pyrazole, Incl. Hydrogenated Unfused (Exc. Phenazone "Antipirina" and Derivatives) in 2022 were Switzerland (US$2.56B), Germany (US$962M), and China (US$860M). In the same year, the main importing countries of Heterocyclic Compounds with Heteroatom / S Nitrogen Exclusively, in the Structure Cycle Pyrazole, Incl. Hydrogenated Unfused (Exc. Phenazone "Antipirina" and Derivatives) were Spain (US$1.19B), Brazil (US$982M), and Slovenia (US$963M).